Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Public Health Genomics and Precision Health Knowledge Base (v8.4)

Note: Javascript is disabled or is not supported by your browser. For this reason, some items on this page will be unavailable. For more information about this message, please visit this page: About CDC.gov.

HuGE Navigator|HuGE Literature Finder|PHGKB

HuGE Literature Finder

Records 1 - 16

Query Trace: Lung Neoplasms and meta-analysis and ERCC1[original query]

Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis. Journal of cellular biochemistry 2017 12 118 (12): 4782-4791. Yu Shao-Nan, Liu Gui-Feng, Li Xue-Feng, Fu Bao-Hong, Dong Li-Xin, Zhang Shu-H Similar articles in PubMed
A Significant Statistical Advancement on the Predictive Values of ERCC1 Polymorphisms for Clinical Outcomes of Platinum-Based Chemotherapy in Non-Small Cell Lung Cancer: An Updated Meta-Analysis. Disease markers 2016 2016 7643981. Han Yali, Liu Jie, Sun Meili, Zhang Zongpu, Liu Chuanyong, Sun Yupi Similar articles in PubMed
Nucleotide excision repair gene ERCC1 19007T>C polymorphism contributes to lung cancer susceptibility: a meta-analysis. Genetic testing and molecular biomarkers 2014 Aug 18 (8): 591-5. Xie Fuyi, Sun Qi, Wu Shengjun, Xie Xinyou, Liu Zhiw Similar articles in PubMed
Nucleotide excision repair gene polymorphisms and prognosis of non-small cell lung cancer patients receiving platinum-based chemotherapy: A meta-analysis based on 44 studies. Biomedical reports 2014 Jul 2 (4): 452-462. Huang Dongning, Zhou Ya Similar articles in PubMed
The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Apr 35 (4): 2905-21. Yang Yanlong, Xian L Similar articles in PubMed
Association studies of ERCC1 polymorphisms with lung cancer susceptibility: a systematic review and meta-analysis. PloS one 2014 9 (5): e97616. Zhu Jinhong, Hua Rui-Xi, Jiang Jing, Zhao Li-Qin, Sun Xiuwei, Luan Jinwei, Lang Yaoguo, Sun Yanqi, Shang Kun, Peng Shiyun, Ma Jianq Similar articles in PubMed
Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports. Gene 2013 Sep 526 (2): 265-74. Xu Tong-Peng, Shen Hua, Liu Ling-Xiang, Shu Yong-Qi Similar articles in PubMed
A meta-analytic review of ERCC1/MDR1 polymorphism and chemosensitivity to platinum in patients with advanced non-small cell lung cancer. Chinese medical journal 2012 Aug 125 (16): 16. Wei HB, Hu J, Shang LH, Zhang YY, Lu FF, Wei M, Yu Y Similar articles in PubMed
Pharmacogenetic role of ERCC1 genetic variants in treatment response of platinum-based chemotherapy among advanced non-small cell lung cancer patients. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2012 Jun 33 (3): 877-84. Yu Dianke, Shi Juan, Sun Tong, Du Xiaoli, Liu Li, Zhang Xiaojiao, Lu Chao, Tang Xiaohu, Li Meng, Xiao Lingchen, Zhang Zhouwei, Yuan Qipeng, Yang Mi Similar articles in PubMed
Nucleotide excision repair gene ERCC1 polymorphisms contribute to cancer susceptibility: a meta-analysis. Mutagenesis 2012 Jan 27 (1): 67-76. Zhang Louqian, Wang Jun, Xu Lin, Zhou Jiannong, Guan Xin, Jiang Feng, Wu Yaqin, Fan Weif Similar articles in PubMed
Excision repair cross complementation group 1 polymorphisms and lung cancer risk: a meta-analysis. Chinese medical journal 2011 Jul 124 (14): 2203-8. Cao Chao, Zhang Yan-mei, Wang Ran, Sun Shi-fang, Chen Zhong-bo, Ma Hong-ying, Yu Yi-ming, Ding Qun-li, Shu Li-hua, Deng Zai-ch Similar articles in PubMed
Polymorphisms of ERCC1 C118T/C8092A and MDR1 C3435T predict outcome of platinum-based chemotherapies in advanced non-small cell lung cancer: a meta-analysis. Archives of medical research 2011 Jul 42 (5): 412-20. Wei Hai-Bo, Lu Xiang-Shi, Shang Li-Hua, Xu Gang, Hu Jing, Che De-Hai, Liu Fang, Wu Ying, Zhang Guang-Mei, Yu Y Similar articles in PubMed
No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis. Lung cancer (Amsterdam, Netherlands) 2011 Jun 72 (3): 370-7. Yin Ming, Yan Jingrong, Voutsina Alexandra, Tibaldi Carmelo, Christiani David C, Heist Rebecca S, Rosell Rafael, Booton Richard, Wei Qing Similar articles in PubMed
Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis. Medical oncology (Northwood, London, England) 2011 Mar 28 (1): 315-21. Wei Shu-zhen, Zhan Ping, Shi Mei-qi, Shi Yi, Qian Qian, Yu Li-ke, Song Yo Similar articles in PubMed
No association of ERCC1 C8092A and T19007C polymorphisms to cancer risk: a meta-analysis. European journal of human genetics : EJHG 2007 Sep 15 (9): 967-73. Li Yuanchun, Gu Shaohua, Wu Qihan, Li Yao, Fu Xuping, Mao Yumin, Huang Yan, Xie Similar articles in PubMed
Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. International journal of medical sciences 2007 4 (2): 59-71. Kiyohara Chikako, Yoshimasu Kouic Similar articles in PubMed

File Formats Help:

How do I view different file formats (PDF, DOC, PPT, MPEG) on this site?

Page last reviewed:Feb 1, 2023
Page last updated:Mar 28, 2023
Content source:

TOP